Child physical abuse (CPA) remained alarmingly consistent during the COVID-19 pandemic, despite shifts in injury patterns.

Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02 clinical study for NeoCast™, a next-generation, ...

Borvo Medical, a portfolio company of NeuroTechnology Investors, announced findings for the company’s FDA-cleared endoport v ...

With clinical success demonstrated at Atlantic Health System, JFK University edical Center, Mount Sinai Health System, St. Lukes Health System, and University of Virginia, Borvo EVAC meets the ...